Clinical relevance of TRKA expression on neuroblastoma: comparison with N-MYC amplification and CD44 expression
Open Access
- 1 April 1997
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 75 (8) , 1151-1155
- https://doi.org/10.1038/bjc.1997.198
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- trk A Gene expression in neuroblastoma. The clinical significance of an immunohistochemical studyCancer, 1995
- CD44H expression by human neuroblastoma cells: relation to MYCN amplification and lineage differentiation.1994
- Immunohistochemical localization of Trk receptor protein in pediatric small round blue cell tumors.1993
- Association between High Levels of Expression of the TRK Gene and Favorable Outcome in Human NeuroblastomaNew England Journal of Medicine, 1993
- Expression of integrin receptors on 45 clinical neuroblastoma specimensInternational Journal of Cancer, 1991
- Single or double consolidation treatment according to remission status after initial therapy in metastatic neuroblastoma: first results of LMCE 3 study in 40 patients.1991
- Clinical value of N-myc oncogene amplification in 52 patients with neuroblastoma included in recent therapeutic protocolsEuropean Journal of Cancer and Clinical Oncology, 1989
- High-dose chemoradiotherapy with bone marrow transplantation as consolidation treatment in neuroblastoma: an unselected group of stage IV patients over 1 year of age.Journal of Clinical Oncology, 1987
- Histopathologic Prognostic Factors in Neuroblastic Tumors: Definition of Subtypes of Ganglioneuroblastoma and an Age-Linked Classification of NeuroblastomasJNCI Journal of the National Cancer Institute, 1984
- A proposed staging for children with neuroblastoma.Children's cancer study group ACancer, 1971